KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Assets (2019 - 2025)

Historic Return on Assets for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to 0.16%.

  • Adaptive Biotechnologies' Return on Assets rose 1800.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.27% for FY2024, which is 300.0% up from last year.
  • Adaptive Biotechnologies' Return on Assets amounted to 0.16% in Q3 2025, which was up 1800.0% from 0.24% recorded in Q2 2025.
  • Adaptive Biotechnologies' Return on Assets' 5-year high stood at 0.14% during Q1 2021, with a 5-year trough of 0.35% in Q2 2024.
  • Its 5-year average for Return on Assets is 0.25%, with a median of 0.26% in 2022.
  • In the last 5 years, Adaptive Biotechnologies' Return on Assets crashed by -1200bps in 2022 and then surged by 1800bps in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Return on Assets (Quarter) stood at 0.22% in 2021, then fell by -6bps to 0.23% in 2022, then crashed by -42bps to 0.33% in 2023, then rose by 11bps to 0.29% in 2024, then surged by 45bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.24% for Q2 2025, and 0.27% during Q1 2025.